NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement

NCT01411657 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Optic Neuropathy/Optic Nerve Stroke

Interventions

DRUG: NT-501 CNTF Implant

Sponsor

Jeffrey L Goldberg